Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06058910 · ClinicalTrials.gov registry record
Bilistick Point-of-care System 2.0 Bilirubin Validation
A clinical trial, sponsored by Kettering Health Network.
- Completed
- Registry status
- 80
- Enrollment target
NCT06058910 is a clinical trial that has completed, run by Kettering Health Network. The registered enrollment target is 80 participants.
The verdict
NCT06058910 has completed, sponsored by Kettering Health Network.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
This is a validation study involving the Bilistick System 2.0 point-of-care bilirubin measuring device. The validation will be conducted by comparing bilirubin measurements utilizing the standard-of-care blood sample collected for both a diagnostic reference device and Bilistick System 2.0 point-of-care device. Whole blood samples collected from male or female newborns (\<2-weeks of age) born at a Kettering Health Network facility to obtain a total of 80 valid comparison pairs between the reference device and the Bilistick System 2.0 point-of-care device with current laboratory standards.
Interventions
- DIAGNOSTIC_TEST Bilistick System 2.0 point-of-care testing device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2024-09-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06058910
The ClinicalTrials.gov registry entry for NCT06058910 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kettering Health Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bilistick System 2.0 point-of-care testing device is the first listed.
NCT06058910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06058910 about?
NCT06058910 is a clinical study titled "Bilistick Point-of-care System 2.0 Bilirubin Validation". This is a validation study involving the Bilistick System 2.0 point-of-care bilirubin measuring device. The validation will be conducted by comparing bilirubin measurements utilizing the standard-of-care blood sample collected for both a diagnostic reference device and Bilistick System 2.0 point-of-...
What is the current status of trial NCT06058910?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2024-02-01. Estimated completion is 2024-09-09.
What interventions are being tested in trial NCT06058910?
The interventions under investigation include: Bilistick System 2.0 point-of-care testing device (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06058910?
This trial is sponsored by Kettering Health Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.